Highland Capital Management Fund Advisors, L.P. Insmed Inc Transaction History

Highland Capital Management Fund Advisors, L.P.

$846 Million
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$22.46 - $29.47 $269,520 - $353,640	-12,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$13.63 - $33.98 $245,340 - $611,640	-18,000 Reduced 60.0%	12,000 $192,000
Q3 2019 Nov 14, 2019	BUY	$15.49 - $25.78 $464,700 - $773,400	30,000 New	30,000 $529,000

Others Institutions Holding INSM

# of Institutions

467

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.33M

Vanguard Group Inc Valley Forge, PA

17.1M
Shares

$1.2 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

14.3M
Shares

$999 Million
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

12.6M
Shares

$881 Million
0.11% of portfolio
Darwin Global Management, Ltd. St. Helier, Y9

10.5M
Shares

$735 Million
62.32% of portfolio
Capital International Investors Los Angeles, CA

6.52M
Shares

$457 Million
0.09% of portfolio

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.48B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.

Account